1. In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus 
A. Carricajo, R. Vermesch, G. Auhert 
Clinical Microbiology and Infection 
Volume 7, Issue 4, Pages (April 2001)
DOI: /j x x
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
Time kill curves: (a) vancomycin (VAN) alone, cefpirome (CPO) alone and vancomycin plus cefpirome for the homogeneous GR-MRSA; (b) vancomycin alone, cefpirome alone and vancomycin plus cefpirome for the heterogeneous GR-MRSA; (c) vancomycin alone, cefpirome alone and vancomycin plus cefpirome for the heterogeneous GS-MRSA.
Clinical Microbiology and Infection 2001 7, DOI: ( /j x x)
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions